2. As of noon trading, Baxter International ( BAX) is up $2.01 (2.93) to $70.59 on heavy volume Thus far, 4.2 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.0 million shares. The stock has ranged in price between $68.74-$71.08 after having opened the day at $68.77 as compared to the previous trading day's close of $68.58. Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $38.1 billion and is part of the health services industry. The company has a P/E ratio of 17.0, below the S&P 500 P/E ratio of 17.7. Shares are up 2.9% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Baxter International a buy, no analysts rate it a sell, and 6 rate it a hold. TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Baxter International Ratings Report now. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.